RT Journal Article
SR Electronic
T1 1025 Tumor-specific CD8+ T cells epigenetically licensed by IL-7R are critical for anti-tumor immunity in melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1133
OP A1133
DO 10.1136/jitc-2023-SITC2023.1025
VO 11
IS Suppl 1
A1 Micevic, Goran
A1 Daniels, Andrew
A1 Flem-Karlsen, Karine
A1 Park, Koonam
A1 Talty, Ronan
A1 McGeary, Meaghan
A1 Mirza, Haris
A1 Blackburn, Holly N
A1 Sefik, Esen
A1 Cheung, Julie F
A1 Hornick, Noah
A1 Aizenbud, Lilach
A1 Joshi, Nikhil
A1 Kluger, Harriet
A1 Iwasaki, Akiko
A1 Bosenberg, Marcus
A1 Flavell, Richard
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1133.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.